C
Cohance Lifesciences
COHANCE Share Price
Healthcare364.20
as on 23 Apr 2026 at 15:25
Market Cap
₹13,933 Cr
PE Ratio
53.70
ROCE
13.36%
COHANCE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
13,933
PE Ratio
53.70
PB Ratio
3.67
Dividend Yield
1.65%
ROE
14.38%
ROCE
13.36%
Book Value (₹)
99.01
Face Value (₹)
1.00
Share Holding Pattern
| Held By | May 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 66.41% | 66.41% | 57.49% | 57.49% | 57.49% |
| Domestic Institutional Investors (DII) | 11.02% | 11.40% | 20.82% | 21.57% | 21.79% |
| Foreign Institutional Investors (FII) | 7.38% | 7.23% | 6.51% | 6.02% | 5.59% |
| Public Investors | 6.63% | 6.40% | 6.42% | 6.76% | 7.04% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
COHANCE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
543064
NSE Scrip Name
COHANCE
ISIN
INE03QK01018



